Literature DB >> 2558701

Beta-adrenoceptor responses to inhaled salbutamol in the elderly.

B J Lipworth1, B F Tregaskis, D G McDevitt.   

Abstract

The purpose of the present study was to evaluate and compare the responsiveness of beta 2-adrenoceptors in elderly and young subjects. Seven healthy elderly volunteers (72 +/- 3 years) were given cumulative doses of inhaled salbutamol (100 micrograms-4000 micrograms) or placebo, following pre-treatment with propranolol 40 mg or placebo. Finger tremor (Tr), plasma potassium (K), and heart rate (HR) were measured at each dose step. There were dose-dependent increases in Tr (P less than 0.001) and HR (P less than 0.001) and falls in K (P less than 0.001), which were completely attenuated by propranolol (P less than 0.001). Comparison with dose-response curves in a group of young (Y) subjects (24 +/- 3 years) given an identical dose protocol of salbutamol showed no evidence of subsensitivity of beta 2-adrenoceptor responses in the elderly (E) group (mean and 95% confidence intervals for maximum responses): delta K -0.90 (-1.1(-)-0.82) mmol l-1 Y, -0.82 (-1.04(-)-0.60) mmol l-1 E, delta Tr 274 (213-335)% Y, 269 (197-342)% E, delta HR 25 (21-28) beats min-1 Y, 26 (21-31) beats min-1 E.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558701      PMCID: PMC1380046          DOI: 10.1111/j.1365-2125.1989.tb03568.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Plasma noradrenaline increases with age.

Authors:  M G Ziegler; C R Lake; I J Kopin
Journal:  Nature       Date:  1976-05-27       Impact factor: 49.962

2.  Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

3.  Reduced beta-adrenoceptor sensitivity in the elderly.

Authors:  R E Vestal; A J Wood; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

4.  Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly.

Authors:  R D Feldman; L E Limbird; J Nadeau; D Robertson; A J Wood
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

5.  Responsiveness to beta-adrenergic receptor stimulation: the effects of age are cardioselective.

Authors:  M J Kendall; K L Woods; M R Wilkins; D J Worthington
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

6.  Effects of atropine on the electrocardiogram in different age groups.

Authors:  P Dauchot; J S Gravenstein
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

7.  Age-related elevation of plasma catecholamine concentration and reduced responsiveness of lymphocyte adenylate cyclase.

Authors:  J F Krall; M Connelly; R Weisbart; M L Tuck
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

8.  Catalytic unit of adenylate cyclase: reduced activity in aged-human lymphocytes.

Authors:  I B Abrass; P J Scarpace
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

9.  Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects.

Authors:  P van Brummelen; F R Bühler; W Kiowski; F W Amann
Journal:  Clin Sci (Lond)       Date:  1981-05       Impact factor: 6.124

10.  Human lymphocyte beta-adrenergic receptors are unaltered with age.

Authors:  I B Abrass; P J Scarpace
Journal:  J Gerontol       Date:  1981-05
View more
  5 in total

1.  Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Beta-adrenergic function in aging. Basic mechanisms and clinical implications.

Authors:  P J Scarpace; N Tumer; S L Mader
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

3.  Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Authors:  D M Newnham; D P Dhillon; J H Winter; C M Jackson; R A Clark; B J Lipworth
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

Review 4.  Adverse drug reactions. An overview of special considerations in the management of the elderly patient.

Authors:  L A Brawn; C M Castleden
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 5.  Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Authors:  S Appleton; T Jones; P Poole; L Pilotto; R Adams; T J Lasserson; B Smith; J Muhammad
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.